May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Glycine and GABA Interact to Regulate the Nitric Oxide/cGMP Signaling Pathway in Retina
Author Affiliations & Notes
  • W.D. Eldred
    Program in Neuroscience, Boston University, Boston, MA
  • D. Yu
    Program in Neuroscience, Boston University, Boston, MA
  • Footnotes
    Commercial Relationships  W.D. Eldred, None; D. Yu, None.
  • Footnotes
    Support  NIH Grant EY04785
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 3451. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W.D. Eldred, D. Yu; Glycine and GABA Interact to Regulate the Nitric Oxide/cGMP Signaling Pathway in Retina . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3451.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Nitric oxide (NO) is a free radical that is important in retinal signal transduction and cyclic guanosine monophosphate (cGMP) is a critical downstream messenger of NO. The NO/cGMP signaling pathway can modulate neurotransmitter release and gap junction coupling in horizontal cells and amacrine cells, and increases the gain of the light response in photoreceptors. However, many of the synaptic mechanisms controlling the retinal production of NO and cGMP remain unclear. Methods: This study used GABAergic and glycinergic antagonists in combination with cGMP immunocytochemistry and NO imaging to investigate how the inhibitory GABAergic and glycinergic systems modulate the production of NO and cGMP. Results: Our data show that blocking glycine receptors (GLYR) with strychnine (STRY) produced moderate increases in cGMP like immunoreactivity (cGMP LI) in select types of amacrine and bipolar cells, and a strong increase in NO induced fluorescence (NO IF). TPMPA, a selective GABACR antagonist, greatly reduced the increases in cGMP LI stimulated by STRY, but did not affect the increase in NO IF stimulated by STRY. Bicuculline (BIC), a GABAAR antagonist, however, enhanced the increases in both the cGMP LI and NO IF stimulated by STRY. Finally, double labeling of NO stimulated cGMP and either GLY or GABA indicated that cGMP predominantly colocalized with GLY. Conclusions: Taken together, these findings support the hypothesis that GLY and GABA interact in the regulation of the NO/cGMP signaling pathway, where GLY primarily inhibits NO production and GABA has a greater effect on cGMP production. Such a serial inhibitory pathway may help to shape the course of signal transduction of the NO/cGMP pathway under different physiological situations.

Keywords: retina: neurochemistry • nitric oxide • neurotransmitters/neurotransmitter systems 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.